FDA Clearance Tracker · K233666
CorVista System with PH Add-On
Last checked: Nov 20, 2026Latest source record: Apr 5, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 5, 2024
Substantially Equivalent
Time to decision
142 days
Received Nov 15, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233666
- Device name
- CorVista System with PH Add-On
- Applicant
- Analytics For Life, Inc.
- Applicant location
- Toronto, CA
- Received
- Nov 15, 2023
- Decided
- Apr 5, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2380
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SAT (Pulmonary Hypertension Machine Learning-Based Notification Software).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K233666
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Analytics For Life, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253576 · Decided Jul 26, 2026 · 251 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.